{"doi":"10.1016/j.cll.2012.06.006","title":"The Prescription Drug Abuse Epidemic","abstract":null,"journal":"Clinics in Laboratory Medicine","year":2012,"id":672392,"datarank":0.4493598410330987,"base_score":2.995732273553991,"endowment":2.995732273553991,"self_citation_contribution":0.4493598410330987,"citation_network_contribution":0.0,"self_endowment_contribution":0.4493598410330987,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":19,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1756774,"name":"Hoi-Ying Elsie Yu","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"The Prescription Drug Abuse Epidemic","abstract":"In the United States, the nonmedical use of prescription drugs is the second most common illicit drug use, behind only marijuana. This article discusses the abuse issues with three of the most widely abused prescription drugs: opioids, central nervous system (CNS) depressants (eg, benzodiazepines), and stimulants (eg, amphetamine-dextroamphetamine and methylphenideate) in the United States. Efforts to deal with the problem are described as well.","is_dataset_classified":null,"base_score":2.995732273553991,"endowment":2.995732273553991,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"22939296","pmcid":null,"openalex_id":"https://openalex.org/W2068652273","authors":[],"funders":[],"total_grants":0,"fwci":1.9554,"citation_percentile":0.84706704,"influential_citations":0,"citation_trend":[{"year":2013,"count":2},{"year":2014,"count":3},{"year":2015,"count":6},{"year":2016,"count":4},{"year":2018,"count":2},{"year":2020,"count":2}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0272271212000777?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0272271212000777?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.cll.2012.06.006","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/22939296","host_type":"repository"}],"fields_of_study":["Attention Deficit Hyperactivity Disorder","Treatment of Major Depression","Neuroethics, Human Enhancement, Biomedical Innovations"],"mesh_terms":["Humans","United States","Substance-Related Disorders","Prescription Drugs","Epidemics"],"keywords":["Young adult","Psychological intervention","Medical prescription","Attendance","Recreational drug use","Prescription Drug Misuse","Medicine","Boredom","Longitudinal study","Prescription drug","Population","Recreation","Psychiatry","Psychology","Clinical psychology","Drug","Gerontology","Social psychology","Environmental health","Pharmacology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-16T08:56:28.862809Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}